Tag: recombinant botulinum toxic

All

The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.

The revised checklist aims to shorten and clarify the current document to better support shared decision-making between patients and surgeons.